ArticleCureus2025
Efficacy and Safety of Robotic Surgery With Sentinel Lymph Node Navigation in Obese Patients With Endometrial Cancer: A Retrospective Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to evaluate the feasibility and safety of robotic-assisted surgery combined with sentinel lymph node navigation surgery (SNNS) in obese patients with International Federation of Gynecology and Obstetrics stage IA endometrial cancer, comparing surgical and oncologic outcomes between obese and non-obese patients.
methodsThis retrospective study evaluated patients who underwent robotic-assisted hysterectomy, bilateral salpingo-oophorectomy, and SNNS at Kagoshima University Hospital between July 2018 and December 2024. The surgical outcomes, including operative time, console time, blood loss, and postoperative complications, of patients with a body mass index (BMI) of ≥ 30 kg/m² and ≥ 35 kg/m² were compared with those of their non-obese counterparts.
resultsAmong the 294 patients evaluated, 39.5% had BMI ≥ 30 kg/m². Compared to non-obese patients, obese patients had significantly longer surgery start to roll-in time (P = 0.0026) and higher intraoperative blood loss (P = 0.018), whereas no significant differences were observed in operative time, console time, or postoperative complications. Patients with BMI ≥ 35 kg/m² had significantly longer operative time (P = 0.03) and surgery start to roll-in time (P = 0.0039) but showed no increased risk of postoperative complications. No cases required conversion to laparotomy.
conclusionsRobotic surgery with SNNS has minimal impact on the surgical outcomes of obese patients with endometrial cancer. Although obesity influences preoperative setup time and intraoperative blood loss, overall surgical safety is maintained. Thus, robotic surgery with SNNS is feasible and safe for these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.